- US12612412utility2026Antiviral Heterocyclic Compounds0 cites
- US12570663utility2026Crystal Forms of an Anti-sars Cov-2 Agent0 cites
- US12552777utility2026Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof0 cites
- US12540141utility2026Spiropyrrolidine Derived Antiviral Agents0 cites
- US12509470utility2025Antiviral Heterocyclic Compounds0 cites
- US12496282utility2025Hepatitis B Antiviral Agents0 cites
- US12479854utility2025Spiropyrrolidine Derived Antiviral Agents0 cites
- US12459923utility2025Tetrazole Containing Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof0 cites
- US12398147utility2025Macrocyclic Spiropyrrolidine Derived Antiviral Agents0 cites
- US12384753utility202517-beta-hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use Thereof0 cites
- US12358921utility2025Antiviral Heterocyclic Compounds0 cites
- US12297209utility2025Benzodiazepine Derivatives as RSV Inhibitors0 cites
- US12281140utility2025Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof0 cites
- US12268694utility2025Combination Pharmaceutical Agents as RSV Inhibitors0 cites
- US12264159utility2025Functionalized Heterocycles as Antiviral Agents0 cites
- US12162857utility2024Antiviral Compounds0 cites
- US12145941utility2024Heterocyclic Antiviral Agents0 cites
- US12145942utility2024Spiropyrrolidine Derived Antiviral Agents0 cites
- US12054493utility2024Hepatitis B Antiviral Agents0 cites
- US12018017utility2024Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof0 cites
Page 1 of 3Next →